Summary
A 15-year-old boy with Tourette's syndrome exhibited severe involuntary self-mutilatory behavior. While clonidine effectively controlled the motor and phonic tics, it failed to ameliorate the self-mutilatory behavior. Administration of oxycodone (50 mg/day) combined with clonidine produced a dramatic reduction in the frequency and severity of the self-mutilatory acts within 12 h. This report indicates that disturbances in the functional interplay between the noradrenergic and opiatergic systems may be important in the pathophysiology of Tourette's syndrome.
This is a preview of subscription content, log in via an institution to check access.
References
Aghajanian CK (1982) Central nor-adrenergic neurons: a locus for the functional interplay between alpha2-adrenoreceptors and opiate receptors. J Clin Psychiatry 43:6, 20–24
Cohen DJ, Young JG, Nathanson AA, Shaywitz BA (1979) Clonidine in Tourette's syndrome. Lancet II:551–552
Gillman MA, Sandyk R (1984) Tourette syndrome: effect of analgesic concentrations of nitrous oxide and naloxone. Br Med J 288:114
Jagger J, Prusoff BA, Cohen DJ, Kidd KK, Carbonari CM, John K (1982) The epidemiology of Tourette's syndrome: a pilot study. Scizo Bull 8:267–278
Leckman JF, Cohen DJ (1983) Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research. Psychiatr Dev 3:301–316
Redmond DE, Huang YH (1982) The primate locus coeruleus and effects of clonidine on opiate withdrawal. J Clin Psychiatry 43:6, 25–29
Shapiro AK, Shapiro E, Bruun RD, Sweet RD (1978) Gilles de la Tourette syndrome. Raven Press, New York
Gillman MA, Sandyk R (1985) The opioid system in Tourette syndrome. Psychiatry Res 15:161–162
Sandyk R (1985) The effect of naloxone in Tourette syndrome. Ann Neurol 18:367–368
Sandyk R (1986) Naloxone withdrawal exacerbates Tourette syndrome. J Clin Psychopharmacol (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sandyk, R. Tourette syndrome: successful treatment with clonidine and oxycodone. J Neurol 233, 178–179 (1986). https://doi.org/10.1007/BF00314429
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314429